Skip to main content

Table 4 Univariate logistic regression to determine predictors of selected cardiovascular disease risk factors

From: The prevalence of selected non-communicable disease risk factors among HIV patients on anti-retroviral therapy in Bushbuckridge sub-district, Mpumalanga province

Variables

Smoking

Alcohol consumption

Hypertension

Overweight

Obesity

Waist Circumference

Age

 18–34 years

Reference (1)

Reference (1)

Reference (1)

Reference (1)

Reference (1)

Reference (1)

  ≥ 35 years

1.5 (0.5–4.8) a

0.3 (0.2–0.6)**

1.6 (1.3–2.1)***

1.5 (0.8–3.1) a

0.7 (0.4–1.4) a

0.97 (0.53–1.78) a

Gender

 Female

Reference (1)

Reference (1)

Reference (1)

Reference (1)

Reference (1)

Reference (1)

 Male

18.9 (0.5–47.4)***

3.6 (2.1–6.3)***

1.5 (0.9–2.4) a

0.9 (0.5–1.9) a

0.09 (0.03–0.3)***

0.3 (0.3–0.5)***

Educational status

 High

Reference (1)

Reference (1)

Reference (1)

Reference (1)

Reference (1)

Reference (1)

 Low

0.9 (0.6–1.5) a

0.7 (0.5–1.1) a

0.8 (0.6–1.1) a

1.6 (1.2–2.3)**

1.0 (0.6–1.9) a

1.1 (0.8–1.6) a

Marital status

 Married

Reference (1)

Reference (1)

Reference (1)

Reference (1)

Reference (1)

Reference (1)

 Single

3.6 (1.3–9.9)*

0.9 (0.4–1.9) a

1.7 (0.9–3.0) a

0.8 (0.4–1.7) a

0.7 (0.3–1.5) a

0.8 (0.4–1.6) a

 Cohabiting

3.9 (1.3–11.9)*

0.9 (0.4–2.1) a

1.1 (0.5–2.4) a

0.3 (0.1–1.0)*

0.7 (0.2–1.9) a

0.7 (0.3–1.9) a

 Divorced

5.6 (1.4–22.2)*

0.7 (0.2–3.1) a

2.2 (0.7–6.0) a

0.2 (0.02–1.2) a

3.1 (0.9–10.4) a

1.6 (0.5–5.1) a

 Separated

2.2 (0.4–11.6) a

0.2 (0.02–1.4) a

2.2 (0.8–5.9) a

0.8 (0.2–2.6) a

0.6 (0.2–2.6) a

1.1 (0.4–3.7) a

 Widowed

1.2 (0.2–6.3) a

0.4 (0.1–1.6) a

2.7 (1.2–6.0)*

1.0 (0.4–2.6) a

1.0 (0.3–2.9) a

1.6 (0.6–4.1) a

Work status

 Working

Reference (1)

Reference (1)

Reference (1)

Reference (1)

Reference (1)

Reference (1)

 Not working

0.8 (0.5–1.1)a

2.8 (0.7–10.8) a

0.9 (0.7–1.1)a

0.08 (0.02–0.3)a

1.2 (0.3–5.1) a

0.8 (2.1–2.9) a

ART Regimen

 FDC

Reference (1)

Reference (1)

Reference (1)

Reference (1)

Reference (1)

Reference (1)

 Dumiva and efavirenz

0.9 (0.3–2.2)a

0.3 (0.1–0.7)*

2.1 (1.1–3.8)*

0.8 (0.4–1.7)a

1.7 (0.8–3.3)a

2.1 (1.2–3.8)*

 Dumiva and alluvia

0.6 (0.1–2.7)a

0.7 (0.2–1.9)a

3.3 (1.4–7.5)**

1.4 (0.5–3.4)a

0.8 (0.3–2.6)a

1.2 (0.5–2.8)a

 Efavirenz and lamividine

–

–

–

3.7 (0.2–59.7)a

–

2.6 (0.2–42.4)a

 Tenamine and neverapine

0.4 (0.05–3.2)a

0.3 (0.1–1.5)a

1.7 (0.7–4.5)a

0.7 (0.2–2.5)a

1.6 (0.6–4.8)a

1.9 (0.7–4.9)a

 Alluvia and tenefovir

–

1.9 (0.3–11.7)a

–

2.4 (0.4–15.0)a

1.2 (0.1–10.6)a

1.7 (0.3–10.6)a

Duration of ART

  ≥ 5 years

Reference (1)

Reference (1)

Reference (1)

Reference (1)

Reference (1)

Reference (1)

 3–4 years

0.8 (0.3–2.5)a

0.6 (0.2–1.6)a

1.6 (0.7–3.5)a

0.7 (0.3–1.5)a

1.6 (0.8–3.2)a

0.8 (0.2–4.2)a

  ≤ 2 years

1.2 (0.5–2.9)a

1.4 (0.7–3.0)a

0.6 (0.3–1.3)a

1.7 (0.9–3.0)a

0.9 (0.4–1.7)a

0.3 (0.04–2.5)a

  1. Values are reported as odds ratios (95%CI); * significant at p < 0.05; ** significant at p < 0.005; *** significant at p < 0.001, aNot significant